ID   OHS-4
AC   CVCL_R724
SY   OHS4
DR   cancercelllines; CVCL_R724
DR   Wikidata; Q38098531
RX   PubMed=1860886;
RX   PubMed=8429272;
CC   Population: Caucasian.
CC   Doubling time: 39 hours (PubMed=1860886).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Glu286Lys (c.856G>A); ClinVar=VCV000183752; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Bone, distal femur; UBERON=UBERON_0004406.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B450 ! OHS
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 12
//
RX   PubMed=1860886; DOI=10.1083/jcb.114.3.577; PMCID=PMC2289099;
RA   Fournier B., Price P.A.;
RT   "Characterization of a new human osteosarcoma cell line OHS-4.";
RL   J. Cell Biol. 114:577-583(1991).
//
RX   PubMed=8429272; DOI=10.1677/joe.0.1360173;
RA   Fournier B., Ferralli J.M., Price P.A., Schlaeppi J.-M.;
RT   "Comparison of the effects of insulin-like growth factors-I and -II on
RT   the human osteosarcoma cell line OHS-4.";
RL   J. Endocrinol. 136:173-180(1993).
//